Erica N Lamkin

5PUBLICATIONS
59CO-AUTHORS
Molecular targetsCell and nuclear divisionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 28, 2026
REV1 Loss Triggers a G2/M Cell-Cycle Arrest Through Dysregulation of Mitotic Regulators.

Brailey Buntin, Madison Guyette, Vihit Gupta

|Sep 27, 2025
Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted Therapy.

Samantha Sekeres, Erica N Lamkin, Eduardo Bravo

|Sep 26, 2025
REV1 inhibition enhances trinucleotide repeat mutagenesis.

Ava Siegel, Daniel Almstead, Naveen Kothandaraman

|Nov 13, 2021
REV1 Inhibition Enhances Radioresistance and Autophagy.

Kanayo E Ikeh, Erica N Lamkin, Andrew Crompton

Pageof 1